KOEF

Core Capabilities - The Cyprus Organization for the Verification of Medicines (CyMVO) was established in February 2017 as a non-profit legal entity. - Its primary role is the implementation of the provisions of the European Directive 2011/62 and Regulation 161/2016 on falsified medicines. - The organization aims to protect European Citizens from falsified (fake) medicine by obstructing their penetration into the legal supply chain. Materials & Processes - Involved in serialization and authentication processes for medicines. Machinery & Technology - Operates a system for the verification of medicines, indicating the use of relevant technologies for serialization and authentication. - Provides support and resources for various system users and providers, including MAHs, Wholesalers, Pharmacies, Pharmaceutical Services, Software Providers, Authorized IT Suppliers, and Stand-alone Systems. Product Types - Focuses on the verification of medicines within the pharmaceutical supply chain. Operational Scale & Reach - Operates within the framework of European Directives and Regulations. - Aims to protect European Citizens, indicating a broad operational scope across Europe. - Serves various stakeholders within Cyprus and the European pharmaceutical supply chain. Quality & Compliance - Ensures compliance with European Directive 2011/62 and Regulation 161/2016 regarding falsified medicines. - Employs a Data Protection Officer to manage personal data processing in line with regulatio...